Well in post 82 you didn't know what it was.
You worded it as though it was separate from the effect from a lack of a mandate, and additionally I was wondering what you consider a market failure in health care to be, seeing as how the private sector would be perfectly content for things like even basic cancer treatments to be the health care free market equivalent to luxury items such as penthouses, new sports cars, and yachts, so long as the margins are high enough.
Recissions and denials of cover are direct consequences of the absence of any universal mandate.
The private sector payers in the US have become phenomenally creative with coming up with ways of serving shareholders at the expense of policyholders. I think that might be because the whole idea of third party payers, right off the bat, are in violation of basic market principals. Where people pay out of pocket, the market is more effective.
If there is a statutory entitlement to health cover (as there is in all UHC systems in all countries that have them), then these phenomena do not arise. Some medical treatments are not provided by some universal systems, but basic health care, chronic conditions, major medical, emergency, maternity, and so on always are.
Gag clauses are supposed to be illegal for health management organisations even in the US. But that is a question of enforceable regulation, not universality.
Gag clauses are supposed to be illegal
now, but that's just one of many, many inventions the private sector has created over the years to enrich investors at the expense of patients.
Non-universality isn't the only plausible reason for higher cost-per-outcome in the US.
I never said it was, and in fact, my post argued the opposite (no nationalized lab services, etc. being behind the the inflated costs (relative to the other developed nations) for the universal coverage after age 65 with Medicare.)
One of the reasons is higher income per person in the US than most other countries.
"Per person" is an average (not a literal average, but taking both into account) between rich and poor, right? How does that even work in a plutonomy?
But in my view the principal reason why all the supply/demand incentives in the US push costs upwards is in most cases tied back to no statutory entitlements (non-universality). Hence in other countries, market-obtained provision (even the insurance provision in most countries) does not manage to overwhelm state buying power.
There
is universality in the over 65 age group (the biggest health care consumers of all, everywhere), and the Medicare costs are
way off the chart compared to the other developed nations for the same age group. The question is: where is all the US Medicare money
going? Once you start trying to answer
that question by looking at the differences in the US system compared to everyone else, you see in pretty clear detail how sometimes anti-market initiatives and government resource allocations are more effective in terms of most people's values than the market is.